RxDoctor Payments Data

Leslie Capin, MD

Dermatology · Englewood, CONPI 1881619443

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 54 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 15 manufacturers reported payments, led by AbbVie at 53.1% of the total. Reporting peaked in 2019 at $713 and has fallen 96.7% since, to $23 in 2024. That places this record below the midpoint for dermatology clinicians in CO, where the typical reported total is $1,877.

$1,605in general payments, 2019–2025

Across 54 payments — averaging $29.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$852
  • Novartis$184
  • Johnson & Johnson$115
  • Galderma Laboratories, L.p.$106
  • Janssen Scientific Affairs, LLC$101
  • Lilly USA, LLC$59
  • plus $188 from 9 others
$8,265in research payments, 2019–2025

Across 6 payments — averaging $1377.50 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Janssen Research & Development, LLC$8K

What the payments were for

  • Food & beverage$1,605100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,605 in reported general payments places this provider in the 45th percentile of 280 dermatology providers in Colorado.

See all dermatology providers in Colorado

Medicare billing

Part B allowed, 2024
$68,989
Medicare patients
356
Services billed
1,356

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Metronidazole12$2,653
Clobetasol Propionate17$1,485
ValacyclovirValacyclovir Hcl32$1,267
Ketoconazole36$690
Fluocinonide14$680
Spironolactone41$593
Doxycycline Hyclate15$525
Minoxidil43$463
Triamcinolone Acetonide42$396
Hydroxychloroquine Sulfate15$100

Paid to pharmacies, not to this prescriber.

Other dermatology in Englewood

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →